PREVENAR 20 susp inj ser pré 0.5 ml
7680692220011
CH-69222
J07AL02
08.08.
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6922201
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4.4 µg, polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 15B conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2.2 µg, polysaccharida 46.2 µg et proteinum corynebacteriae diphtheriae CRM 197 51 µg, adjuvans: aluminium 0.125 mg ut aluminii phosphas, acidum succinicum, natrii chloridum corresp. natrium 1.73 mg, polysorbatum 80, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml,
Articles (1)
Prevenar 20, Injektionssuspension in einer Fertigspritze
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
4.4 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.2 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
46.2 UG | Substance | WIIS |
|
(N/A)
|
51.0 UG | Substance | WIIS |
|
(N/A)
|
0.125 MG | Substance | HIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.73 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 80.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2024
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69222
- Drug name
- Prevenar 20, Injektionssuspension in einer Fertigspritze
- Galenic form
- INJFS
- ATC Code
- J07AL02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/03/2024
- Authorization expiration date
- 25/03/2029
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PREVENAR 20 susp inj ser pré 0.5 ml
- Description (DE)
- PREVENAR 20 Inj Susp Fertspr 0.5 ml
- Market launch
- 26/03/2024
- Narcotic (BTM)
- No